Effectiveness of the Advocate Lutheran General Survivorship Center Programs

NCT02660996 | Completed DMC

• 1 other identifier: 5857
• Study Type: observational
• Target: 22
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this observational study is to assess the effectiveness of the Advocate Lutheran General Survivorship Center's Programs by measuring the following outcomes of interest on participating patients:

1. 1.Quality of life
2. 2.Distress level
3. 3.Satisfaction with the Survivorship Program

Conditions

Cancer; Quality of Life

Outcome Measures

Primary Outcomes (1)

• Quality of life

  Questionnaire that includes 36 questions and asks how patients feel their illness has impacted them and their lifestyle with scoring as noted.

  6-8 months

Secondary Outcomes (2)

• Distress level

  6-8 months

• Satisfaction with the Survivorship Program

  6-8 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Newly diagnosed cancer patients who see one of the oncologists at The Advocate Lutheran General Hospital Center of for Advanced Care. Patients who older than 18 years of age, male or female, and any race are eligible. Patients who are new to the Survivorship Center or only visited once are eligible.

You may qualify if:

• Patients older than 18 years of age, any gender, and any race
• Newly diagnosed with any type of cancer and now seeing one of the oncologists at the Advocate Lutheran General Hospital's Center for Advanced Care
• Patients new to the Survivorship Center or only visited once
• Must attend at least four classes in a two month period (any class, any time, any day)
• Able to consent
• English speaking patient

You may not qualify if:

• Not a newly diagnosed cancer patient
• Patients under the age of 18
• Pregnant patients
• Prisoners
• Unable to consent
• Non - English speaking patient

Sponsors & Collaborators

• Wake Forest University Health Sciences: lead

Study Sites (1)

Advocate Lutheran General Hospital

Park Ridge, Illinois, 60068, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

• Sigrun Hallmeyer, MD

  Advocate Lutheran General Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 14, 2016
• First Posted: January 21, 2016
• Study Start: October 1, 2016
• Primary Completion: March 31, 2017
• Study Completion: August 14, 2017
• Last Updated: October 4, 2024

Record last verified: 2019-07

Data Sharing

• IPD Sharing: Will share

Locations

US (1)